top glp 1 drug companies GLP-1 Analogues Market Expands with Diabetes and Obesity Demand | rahulmengane rm posted on the topic Compare GLP-1 Options | Ozempic

One helpful tool is Sustainalytics ESG Risk Rating, which offers valuable insights into companies exposure to material ESG issues and evaluates their strategies to address such risks

We were determined to develop a weight-loss solution that was clinically effective, backed by science, deeply personalized and sustainable

Compared to classical exenatide given twice daily (BID, the once-weekly (QW) formulation at a 2 mg dose level provides a relatively stable plasma concentration at steady-state (300 pg/ml) because of the more continuous delivery of the drug, with equal (or slightly improved) efficacy on glycemic control and body weight after 24 and 30 wk of treatment [888]

They may need to refer you to a specialist weight management service for weight loss

oral and injectable forms are FDA-approved for T2DM, but only the injectable form is approved for obesity